Stilla Technologies
Vendors, kit makers, and service providers using dPCR are crafting diverse strategies to ramp up adoption of the technology.
Top Five Articles on 360Dx Last Week: Blood-Based Testing in Neurology; End of NHS England; More
Last week, readers were most interested in a story about how blood-based testing is making increasing inroads for neurological conditions.
Digital PCR's Clinical Push Could be Accelerated by Bio-Rad Acquisition of Stilla Technologies
Premium
Will the acquisition finally lead to an accelerated adoption of digital PCR in the clinical space?
Bio-Rad plans to drive adoption of Stilla's all-in-one Nio+ dPCR system while also incorporating its own assays to expand the menu.
The firm is seeing the fruit of a two-year investment in transitioning from a research lab to a clinical focus.